25 assets in Malignant Germ Cell Tumor

Therapeutic assets addressing Malignant Germ Cell Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Malignant Germ Cell Tumor	Children's Oncology Group	P3	BB (66)
Etoposide Malignant Germ Cell Tumor	Children's Oncology Group	P3	BB (66)
Bleomycin Malignant Germ Cell Tumor	Children's Oncology Group	P3	B (60)
Cis-Diamminedichloroplatinum Ii Malignant Germ Cell Tumor	Children's Oncology Group	P3	B (60)
Olaparib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	B (57)
Palbociclib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	B (57)
PI3K/MTOR INHIBITOR LY3023414 Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	B (57)
Tazemetostat Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	B (57)
Vemurafenib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (55)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)- Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Ensartinib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Ivosidenib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Larotrectinib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493 Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Pembrolizumab Malignant Germ Cell Tumor	M.D. Anderson Cancer Center	P2	CCC (53)
Selpercatinib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Selumetinib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Ulixertinib Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Onivyde Malignant Germ Cell Tumor	St. Jude Children's Research Hospital	P1/2	CCC (48)
Talazoparib Malignant Germ Cell Tumor	St. Jude Children's Research Hospital	P1/2	CCC (48)
Fludarabine Malignant Germ Cell Tumor	St. Jude Children's Research Hospital	P1	CC (47)
b7-h3 car t cells Malignant Germ Cell Tumor	St. Jude Children's Research Hospital	P1	CC (43)
Cyclophosphamide Malignant Germ Cell Tumor	St. Jude Children's Research Hospital	P1	CC (43)
Mesna Malignant Germ Cell Tumor	St. Jude Children's Research Hospital	P1	CC (43)
Ivocizumab Malignant Germ Cell Tumor	Fudan University	P2	NR ()